As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan®) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
Transcript (slightly modified)
What effect has the Narcan program had on the local police officers?
Narcan has really turned out to have several advantages. Not only are we saving the life of that individual, making a difference where you’re bringing back from the light as they almost walked into the light, but more importantly it’s changed the image of who the victim is, who that individual is. It’s somebody’s son, it’s somebody’s daughter, it’s someone’s loved one, and I think the police officers now can relate better to that.
I think the other thing is that before they were just standing around being helpless. The other people would say “do something, do something,” but there was nothing that they could do. They had to wait for either the first aid squad or EMTs to show up. Now they can actively participate, and what happens is once they do participate and they bring that person back to life, to them it’s a life-changing moment. We have acknowledged that by acknowledging that police officer for completing that event and doing a tremendous job.
It’s heartwarming to the police officer, I think it’s changed the image of the police officer, and it’s also changed the image in the police officer’s eye of that individual who almost died. So the result is that there’ve been many, many different advantages to the Narcan program besides the fact that we brought somebody from the jaws of death.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More